Ritter Pharmaceuticals' IPO

Ritter Pharmaceuticals raised a round of funding on June 25, 2015. Investors include Public.

Ritter Pharmaceuticals is a specialty pharmaceutical company developing therapeutics based upon colonic adaptation to treat gastrointestinal diseases with an initial focus on lactose intolerance. Colo…

Articles about Ritter Pharmaceuticals' IPO: